Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.21%68.971.0%$928.43m
AMGNAmgen Inc.
-0.30%172.090.8%$653.49m
BIIBBiogen Inc.
-1.41%283.580.9%$519.52m
CELGCelgene Corporation
-1.23%117.801.0%$475.06m
REGNRegeneron Pharmaceuticals, Inc.
-3.00%359.101.9%$331.01m
ALXNAlexion Pharmaceuticals, Inc.
-1.39%129.012.0%$295.68m
TSROTESARO, Inc.
-3.24%183.7815.3%$189.56m
INCYIncyte Corporation
-1.66%119.352.3%$160.83m
ILMNIllumina, Inc.
-1.00%160.693.9%$143.02m
VRTXVertex Pharmaceuticals Incorporated
-1.25%84.722.6%$137.65m
EXELExelixis, Inc.
-2.48%22.065.5%$124.76m
CLVSClovis Oncology, Inc.
-3.81%58.8616.4%$122.78m
AAgilent Technologies, Inc.
0.00%51.341.7%$116.33m
ACADACADIA Pharmaceuticals Inc.
0.05%39.1619.0%$93.54m
BMRNBioMarin Pharmaceutical Inc.
-0.77%89.104.0%$89.73m

Company Profile

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.